NSYS · Nortech Systems Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 12, 2026TL;DR. Nortech Systems reported Q2 2026 net sales of $33.5 million, up 9.3% year-over-year, with gross margin expanding 120 basis points to 17%, but operating income declined to $623,000 from $742,000 as higher incentive compensation pressured expenses; total backlog grew 19.8% year-over-year to $93.8 million while the company used $2.4 million in cash from operations and ended the quarter with only $1.7 million of cash.
- + Q2 net sales rose 9.3% year-over-year to $33.5 million, with YTD sales up 10.9% to $63.9 million
- + Gross margin expanded 120 basis points to 17% on improved manufacturing cost absorption
- + Total backlog grew 19.8% year-over-year to $93.8 million, led by aerospace & defense and medical imaging
- + 90-day shipment backlog rose 25.8% year-over-year to $33.4 million
- + Medical device sales jumped 36% year-over-year on existing-customer demand and new-program ramp
- + YTD operating income swung to $670,000 from a $(871,000) loss a year ago
- − Q2 operating income declined to $623,000 from $742,000 as incentive compensation expense rose $533,000 year-over-year
- − Aerospace & defense sales fell 12.8% in Q2 due to a customer reducing post-COVID inventory
- − Industrial sales declined 4.7% on customer inventory adjustments and Mexico transfer disruptions
- − Q2 EBITDA fell 12.6% year-over-year to $938,000
- − Diluted EPS slipped to $0.11 from $0.12 in Q2 2025
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 90-day backlog | $33.4M | as of June 30, 2026 | — |
| ADJUSTED EBITDA non-GAAP | $1.29M | Six months ended June 30, 2026 | — |
| Total backlog | $93.8M | as of June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NSYS
this stock
Nortech Systems Inc
|
$28.63M | +35.0% | -15.0% | 27.1 | 0.1% |
|
ABT
Abbott Laboratories
|
$179.20B | -16.9% | +5.7% | 33.3 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -3.4% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -15.2% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.02B | -52.8% | +12.5% | 18.4 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NSYS | -11.6% | -14.9% | -29.6% | -10.5% | +35.0% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -10.1% | -14.0% | -37.3% | -11.0% | +22.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.